Actos (Pioglitazone)

Since 1999, the prescription drug Actos is a medication which has been prescribed to hundreds of thousands of diabetics to control their blood glucose (sugar) levels. However, on June 15, 2011, the United States Food and Drug Administration issued the following Safety Announcement about Actos: “The U.S. Food and Drug Administration (FDA) is informing the public that use of the diabetes medication Actos (pioglitazone) for more than one year may be associated with an increased risk of bladder cancer. Information about this risk will be added to the Warnings and Precautions section of the label for pioglitazone-containing medicines. The patient Medication Guide for these medicines will also be revised to include information on the risk of bladder cancer.”

As a result of the link between Actos and bladder cancer, France took Actos off its market, and Germany ceased all new Actos prescriptions. However, the Japanese drug manufacturer Takeda Pharmaceuticals. Inc. continues to market Actos across the United States, and this drug is still available in California. Some studies show that the risk of developing bladder cancer due to Actos increases with larger doses and the number of years a patient takes this drug.

If your physician has prescribed Actos for you, you should immediately discuss whether there are safer alternative drugs for you. After weighing the risks and benefits, you and your physician can determine what drug is best for you. If you live in California, have taken Actos, and have developed bladder cancer, you should know that attorney and physician Paul J. Molinaro is available to answer your legal questions and help you determine whether you are entitled to compensation from the manufacturer of this drug. You can reach Paul J. Molinaro, M.D. J.D. toll free at (888)MDJDLAW. The initial consultation is also free, and if Paul determines that you have a case, and you decide to hire Paul, he will represent you on a contingent basis.

Ratings and Reviews